Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000809355 | SCV000949505 | uncertain significance | Epileptic encephalopathy | 2019-04-23 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. The current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in RYR3 cause disease. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site, but this prediction has not been confirmed by published transcriptional studies. This variant has not been reported in the literature in individuals with RYR3-related disease. This variant is present in population databases (rs549279246, ExAC 0.009%). This sequence change affects a donor splice site in intron 83 of the RYR3 gene. It is expected to disrupt RNA splicing and likely results in an absent or disrupted protein product. |
Lupski Lab, |
RCV001007854 | SCV001167552 | uncertain significance | Flexion contracture | no assertion criteria provided | research | ||
OMIM | RCV003166284 | SCV003853597 | pathogenic | Congenital myopathy 20 | 2023-04-07 | no assertion criteria provided | literature only |